コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 st that engineered cells are able to promote bystander suppression.
2 with both parasite Ag-specific tolerance and bystander suppression.
3 t antigens induces Tregs that are capable of bystander suppression.
4 tration and identifying strategies to induce bystander suppression.
5 mmune neuritis), indicating they function by bystander suppression.
6 eta, IL-10, or both) was the primary mode of bystander suppression.
8 DCs, was found to mediate both tolerance and bystander suppression against diverse T cell specificiti
9 in vivo by delayed-type hypersensitivity or bystander suppression against mycobacterial Ags in CFA.
10 lonotypic TCR in vivo, but failed to mediate bystander suppression and did not prevent Th17 cells usi
13 (+) T cells to examine the cellular basis of bystander suppression associated with oral tolerance in
14 This effect is specific and does not involve bystander suppression because treatment with MBP-IgG doe
16 ese results shed light upon the mechanism of bystander suppression by donor Ag-specific TR in patient
21 tigen-dependent linked DTH unresponsiveness (bystander suppression) in allograft recipients requires
22 the release of interleukin-10, implicating a bystander suppression mechanism that holds promise for t
24 uced by continuous OVA exposure demonstrated bystander suppression of cockroach allergen-mediated air
26 s (DC), but not monocyte APCs, could mediate bystander suppression of EBV-specific recall response.
27 ores normoglycemia, most likely by localized bystander suppression of pathogenic IL-17-producing cell
29 xtures of plasmacytoid DC (pDC) and T cells, bystander suppression of the response to a colocalized r
30 ot act as an antagonist in vivo but mediates bystander suppression, probably by the generation of reg
31 o CIX and CII were specific, suggesting that bystander suppression, rather than cross-reactivity with
32 suboptimal costimulatory molecules and IL-10 bystander suppression to drive a dual-modal T cell modul
33 strategy for generating autoantigen-specific bystander suppression useful for treatment of complex au
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。